Author name: Avenna Admin

How glycomics can be used to measure Chronic inflammation?

Intro/Instructions / By

How glycomics can be used to measure Chronic inflammation? Chronic inflammation is a major health concern worldwide, associated with numerous diseases, including cancer, cardiovascular disease, and diabetes. While inflammation is a natural response to injury or infection, persistent or chronic inflammation can lead to tissue damage and contribute to the development of various diseases. Recent …

How glycomics can be used to measure Chronic inflammation? Read More »

Introduction to Avenna

Intro/Instructions / By

Introduction to Avenna        In this video, we explain how our in-vitro diagnostic platform technology- GlyHealth can enhance healthcare for chronic inflammatory diseases. We explain the benefits of our biomarkers for different members of healthcare ecosystem, including clinicians and drug development companies.   BACK TO MEDIA GALLERY

ImmunofrailityTest- Instruction video

Intro/Instructions / By

Immunofraility Test. Instruction video        In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease.

Avenna Women in Innovation

Presentations / By

Avenna Women in Innovation video 2021        In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of …

Avenna Women in Innovation Read More »

https://www.linkedin.com/posts/avenna-ltd_glycans-are-crucial-in-covid-19-infection-activity-6785481637766414336-4xrj

WuXi HealthCare forum presentation

Presentations, Conference / By

WuXi HealthCare forum presentation In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease. Click here to see …

WuXi HealthCare forum presentation Read More »

Early intervention before disease progression using glyhealth

Articles / By

Early intervention before disease progression using Gly-Health   The club tracks down the latest scientific research on the causes of aging and effects on life expectancy and keeps you abreast of the wider impacts of life extension and the consequences for society when it arrives. Here is an article about early intervention before disease progression …

Early intervention before disease progression using glyhealth Read More »

Avenna Ltd

Culham Science Centre
Oxfordshire
OX14 3EB, UK

info@avenna.com

Privacy Policy

Subscribe and get access to exclusive resources and discounts.

© 2022 Avenna LTD. All Rights Reserved